It's a baby and the bathwater situation. Some pharma incentives are perverse, and some people involved in the past and present were behind it. It's worth being

It's a baby and the bathwater situation. Some pharma incentives are perverse, and some people involved in the past and present were behind it. It's worth being cautious about taking things at face value, but it's always worth being skeptical. Assuming everyone in the company has the same character as whichever employees you anchor on and assuming evidence is falsified is also suboptimal.